Invention Grant
- Patent Title: Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor
-
Application No.: US17290656Application Date: 2019-11-01
-
Publication No.: US11951182B2Publication Date: 2024-04-09
- Inventor: Hiromi Kumon , Bryan Burt
- Applicant: Momotaro-Gene Inc.
- Applicant Address: JP Okayama
- Assignee: Momotaro-Gene Inc.
- Current Assignee: Momotaro-Gene Inc.
- Current Assignee Address: JP Okayama
- Agency: Foley & Lardner LLP
- International Application: PCT/JP2019/043151 2019.11.01
- International Announcement: WO2020/091066A 2020.05.07
- Date entered country: 2021-04-30
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K38/17 ; A61K39/00 ; A61K39/395 ; A61P35/00 ; C12N15/86
Abstract:
An object of the present invention is to provide a method of treating thoracic cancer using a checkpoint inhibitor in combination with Ad-REIC/Dkk-3. The present invention is a pharmaceutical composition for treating thoracic cancer comprising REIC/Dkk-3 in combination with acheck point inhibitor and a method for treating thoracic cancer by administering Ad-REIC/Dkk-3 and a check point inhibitor to a thoracic cancer patient.
Public/Granted literature
- US20210402010A1 A COMBINATION THERAPY FOR TREATMENT OF THORACIC CANCER USING Ad-REIC/Dkk-3 AND A CHECKPOINT INHIBITOR Public/Granted day:2021-12-30
Information query
